首页 > 最新文献

Yonago acta medica最新文献

英文 中文
Predictors of Renal Replacement Therapy Requirement in Acute Kidney Injury Due to Urinary Sepsis: A Single-Center Retrospective Study. 尿脓毒症引起的急性肾损伤需要肾脏替代治疗的预测因素:一项单中心回顾性研究。
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-07-23 eCollection Date: 2025-08-01 DOI: 10.33160/yam.2025.08.010
Ryusei Yasukawa, Takehiro Sejima, Hideto Iwamoto, Shuichi Morizane

Background: Urosepsis is defined as sepsis caused by an infection of the urogenital tract and is a systemic response to infection. Urosepsis is commonly treated in the intensive care unit (ICU) because of its acute and potentially lethal nature. Acute kidney injury (AKI) is a common complication of septic shock in ICU patients. This study predicted cases in which patients required renal replacement therapy (RRT) during the early stages of hospitalization. We also examined the relationship between the clinical information obtained at admission and the subsequent need for RRT.

Methods: This single-center, retrospective, observational study included 114 patients with sepsis caused by tract infections. We examined the multiple factors associated with AKI using clinical and social information. AKI was defined according to the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines, with severe AKI defined as AKI requiring RRT. Logistic regression analyses were performed to identify the significant factors associated with severe AKI based on the information obtained at the time of admission.

Results: Severe AKI occurred in 12 patients. Multivariate analysis revealed that two factors were significantly associated with severe AKI: a high leukocyte count in the peripheral blood (> 22,100/μL) at admission (odds ratio: 21.972, 95% CI: 1.798-268.481) and the administration of vasopressors (odds ratio: 13.327, 95% CI: 1.009-176.091).

Conclusion: Physicians should be vigilant of the potential development of severe AKI in cases of urosepsis, particularly when patients require vasopressor and present with extremely high peripheral blood leukocyte counts at admission.

背景:尿脓毒症被定义为由泌尿生殖道感染引起的脓毒症,是对感染的全身反应。尿脓毒症通常在重症监护病房(ICU)治疗,因为它的急性和潜在的致命性。急性肾损伤(AKI)是ICU患者感染性休克的常见并发症。本研究预测患者在住院早期需要肾脏替代治疗(RRT)的病例。我们还研究了入院时获得的临床信息与随后RRT需求之间的关系。方法:这项单中心、回顾性、观察性研究纳入了114例由呼吸道感染引起的脓毒症患者。我们利用临床和社会信息检查了与AKI相关的多种因素。AKI是根据肾脏疾病改善总体结局(KDIGO)临床实践指南定义的,重度AKI定义为需要RRT的AKI。根据入院时获得的信息,进行Logistic回归分析以确定与严重AKI相关的重要因素。结果:12例患者发生严重AKI。多因素分析显示,两个因素与严重AKI显著相关:入院时外周血白细胞计数高(bb0 22100 /μL)(优势比:21.972,95% CI: 1.798-268.481)和血管加压药物的使用(优势比:13.327,95% CI: 1.009-176.091)。结论:医生应警惕尿脓毒症患者可能发展为严重AKI,特别是当患者入院时需要血管加压剂和外周血白细胞计数极高时。
{"title":"Predictors of Renal Replacement Therapy Requirement in Acute Kidney Injury Due to Urinary Sepsis: A Single-Center Retrospective Study.","authors":"Ryusei Yasukawa, Takehiro Sejima, Hideto Iwamoto, Shuichi Morizane","doi":"10.33160/yam.2025.08.010","DOIUrl":"10.33160/yam.2025.08.010","url":null,"abstract":"<p><strong>Background: </strong>Urosepsis is defined as sepsis caused by an infection of the urogenital tract and is a systemic response to infection. Urosepsis is commonly treated in the intensive care unit (ICU) because of its acute and potentially lethal nature. Acute kidney injury (AKI) is a common complication of septic shock in ICU patients. This study predicted cases in which patients required renal replacement therapy (RRT) during the early stages of hospitalization. We also examined the relationship between the clinical information obtained at admission and the subsequent need for RRT.</p><p><strong>Methods: </strong>This single-center, retrospective, observational study included 114 patients with sepsis caused by tract infections. We examined the multiple factors associated with AKI using clinical and social information. AKI was defined according to the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines, with severe AKI defined as AKI requiring RRT. Logistic regression analyses were performed to identify the significant factors associated with severe AKI based on the information obtained at the time of admission.</p><p><strong>Results: </strong>Severe AKI occurred in 12 patients. Multivariate analysis revealed that two factors were significantly associated with severe AKI: a high leukocyte count in the peripheral blood (> 22,100/μL) at admission (odds ratio: 21.972, 95% CI: 1.798-268.481) and the administration of vasopressors (odds ratio: 13.327, 95% CI: 1.009-176.091).</p><p><strong>Conclusion: </strong>Physicians should be vigilant of the potential development of severe AKI in cases of urosepsis, particularly when patients require vasopressor and present with extremely high peripheral blood leukocyte counts at admission.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"68 3","pages":"220-226"},"PeriodicalIF":0.6,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12343178/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144849175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Burn Injury-Induced HMGB1 Release Leads to Lung Damage Through Pulmonary Intercellular Barrier Disruption. 烧伤诱导的HMGB1释放通过肺细胞间屏障破坏导致肺损伤。
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-07-23 eCollection Date: 2025-08-01 DOI: 10.33160/yam.2025.08.012
Yusuke Okawara, Yosuke Horikoshi, Kenichi Matsuda, Yugo Kato, Masato Homma, Kazuhiro Nakaso, Takahiro Ueda

Background: Extensive burns induce systemic inflammation and increase vascular permeability, resulting in dehydration and edema. During burn injury, the release of high-mobility group box 1 (HMGB1) from damaged cells may promote an inflammatory response. In this study, we examined the relationship between changes in blood HMGB1 levels, vascular permeability, and lung tissue damage following burn injury.

Methods: We examined changes in blood levels of HMGB1 using a mouse model of skin burns. Additionally, we examined intercellular adhesion structures that regulate the barrier function both the skin and lung. To assess changes in vascular permeability, lung tissues of mice with burn injuries were stained with Evans blue. To elucidate the role of HMGB1 in mediating the observed changes, cultured human vascular endothelial cells (HUVECs) and alveolar epithelial cells (H441) were treated with mouse burn serum or HMGB1 protein.

Results: Herein, we observed HMGB1 leakage from burned mouse skin and elevated blood levels of HMGB1. Vascular permeability experiments using Evans blue staining confirmed increased permeability in the lung tissues of mice with burn injuries. Measurement of transendothelial electrical resistance revealed enhanced vascular permeability and reduced expression of the intercellular junction proteins in HUVECs. Conversely, treatment of H441 cells with HMGB1 disrupted the location and expression of the tight junction protein, zonula occludens-1. Treatment with the anti-HMGB1 antibody suppressed the disruption of cell-cell junctions in HMGB1-treated cells. These altered adhesion structures were also detected in pulmonary cells of mice with burn injuries. In H441 cells, HMGB1 treatment increased the activation of atypical protein kinase C (aPKC), which is essential for the formation of epithelial-specific cell-cell junctional structures. Inhibition of aPKC suppressed HMGB1-induced disruption of intercellular junction structures.

Conclusion: Collectively, these findings suggest that HMGB1-mediated dysregulation of aPKC activity may underlie burn injury-induced vascular hyperpermeability by disrupting cell-cell adhesion.

背景:大面积烧伤引起全身炎症,增加血管通透性,导致脱水和水肿。在烧伤过程中,受损细胞释放高迁移率组框1 (HMGB1)可能促进炎症反应。在这项研究中,我们研究了烧伤后血液HMGB1水平变化、血管通透性和肺组织损伤之间的关系。方法:采用皮肤烧伤小鼠模型检测HMGB1血药浓度的变化。此外,我们研究了调节皮肤和肺屏障功能的细胞间粘附结构。为了评估血管通透性的变化,对烧伤小鼠肺组织进行Evans蓝染色。为了阐明HMGB1在介导上述变化中的作用,我们用小鼠烧伤血清或HMGB1蛋白处理培养的人血管内皮细胞(HUVECs)和肺泡上皮细胞(H441)。结果:我们观察到烧伤小鼠皮肤HMGB1渗漏和HMGB1血药浓度升高。Evans蓝染色血管通透性实验证实,烧伤小鼠肺组织通透性增加。经内皮电阻测量显示HUVECs血管通透性增强,细胞间连接蛋白表达减少。相反,用HMGB1处理H441细胞,会破坏紧密连接蛋白zonula occludens-1的位置和表达。抗hmgb1抗体抑制了hmgb1处理细胞中细胞-细胞连接的破坏。在烧伤小鼠的肺细胞中也检测到这些粘附结构的改变。在H441细胞中,HMGB1处理增加了非典型蛋白激酶C (aPKC)的激活,这对于上皮特异性细胞-细胞连接结构的形成至关重要。抑制aPKC抑制hmgb1诱导的细胞间连接结构破坏。结论:总之,这些发现表明hmgb1介导的aPKC活性失调可能是通过破坏细胞-细胞粘附导致烧伤诱导的血管高通透性的基础。
{"title":"Burn Injury-Induced HMGB1 Release Leads to Lung Damage Through Pulmonary Intercellular Barrier Disruption.","authors":"Yusuke Okawara, Yosuke Horikoshi, Kenichi Matsuda, Yugo Kato, Masato Homma, Kazuhiro Nakaso, Takahiro Ueda","doi":"10.33160/yam.2025.08.012","DOIUrl":"10.33160/yam.2025.08.012","url":null,"abstract":"<p><strong>Background: </strong>Extensive burns induce systemic inflammation and increase vascular permeability, resulting in dehydration and edema. During burn injury, the release of high-mobility group box 1 (HMGB1) from damaged cells may promote an inflammatory response. In this study, we examined the relationship between changes in blood HMGB1 levels, vascular permeability, and lung tissue damage following burn injury.</p><p><strong>Methods: </strong>We examined changes in blood levels of HMGB1 using a mouse model of skin burns. Additionally, we examined intercellular adhesion structures that regulate the barrier function both the skin and lung. To assess changes in vascular permeability, lung tissues of mice with burn injuries were stained with Evans blue. To elucidate the role of HMGB1 in mediating the observed changes, cultured human vascular endothelial cells (HUVECs) and alveolar epithelial cells (H441) were treated with mouse burn serum or HMGB1 protein.</p><p><strong>Results: </strong>Herein, we observed HMGB1 leakage from burned mouse skin and elevated blood levels of HMGB1. Vascular permeability experiments using Evans blue staining confirmed increased permeability in the lung tissues of mice with burn injuries. Measurement of transendothelial electrical resistance revealed enhanced vascular permeability and reduced expression of the intercellular junction proteins in HUVECs. Conversely, treatment of H441 cells with HMGB1 disrupted the location and expression of the tight junction protein, zonula occludens-1. Treatment with the anti-HMGB1 antibody suppressed the disruption of cell-cell junctions in HMGB1-treated cells. These altered adhesion structures were also detected in pulmonary cells of mice with burn injuries. In H441 cells, HMGB1 treatment increased the activation of atypical protein kinase C (aPKC), which is essential for the formation of epithelial-specific cell-cell junctional structures. Inhibition of aPKC suppressed HMGB1-induced disruption of intercellular junction structures.</p><p><strong>Conclusion: </strong>Collectively, these findings suggest that HMGB1-mediated dysregulation of aPKC activity may underlie burn injury-induced vascular hyperpermeability by disrupting cell-cell adhesion.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"68 3","pages":"237-249"},"PeriodicalIF":0.6,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12343182/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144849168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utilization of Explainable Artificial Intelligence (XAI)-Powered Computer-Aided Detection (CAD) System on Chest X-Ray Abnormalities in Health Check-Ups. 可解释人工智能(XAI)驱动的计算机辅助检测(CAD)系统在健康检查中胸部x线异常的应用。
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-07-23 eCollection Date: 2025-08-01 DOI: 10.33160/yam.2025.08.002
Shizuka Nishii, Katsuyuki Tomita, Hirokazu Touge, Hiroyuki Yamamoto, Keiji Shigeshiro, Akira Yamasaki

Background: We designed a single-center retrospective study comparing the performance of commercially explainable artificial intelligence (XAI)-powered computer-aided detection (CAD) system of abnormal findings on chest X-rays (CXR) with that of non-experts, and pulmonology experts.

Methods: A total of 1,262 images of 1,262 subjects (mean age 49 years; 52% female) and 1,252 images of 1,252 subjects (mean age 51 years; 51% female) were obtained from DICOM formats in Hakuai Hospital Health Check-up Center, in the pre-and post-implementing XAI-powered CAD period, respectively. The ultimate decision of abnormality on CXR was made by two pulmonology experts. The diagnostic accuracy metrics were measured accuracy and negative predictive value (NPV) for detecting abnormality on CXR.

Results: XAI-powered CAD systems achieved an accuracy of 0.84 (95% confidential interval [CI] 0.82-0.86) and NPV of 1.00 (95% CI 0.99-1.00) to detect the abnormality on CXR. For determining nodular shadows, it was found to be non-inferior to the pulmonology experts with an accuracy of 0.94 (95% CI 0.92-0.95), and NPV of 1.00 (95% CI 0.99-1.00). It tended to overestimate the abnormality of heart enlargement and pleural thickening with a tendency for lower sensitivity.

Conclusion: It seems likely that in the future, the most accurate screening CXR will be a double check combining with the pulmonology experts with XAI-powered CAD systems.

背景:我们设计了一项单中心回顾性研究,比较商业上可解释的人工智能(XAI)驱动的计算机辅助检测(CAD)系统在胸部x光片(CXR)异常表现与非专家和肺科专家的表现。方法:1262例受试者(平均年龄49岁;女性占52%),1252名受试者(平均年龄51岁;(51%为女性)分别在实施XAI-powered CAD之前和之后在白会医院健康检查中心的DICOM格式中获得。两名肺科专家最终决定是否在x光片上显示异常。诊断准确性指标为测量准确性和阴性预测值(NPV),用于检测CXR异常。结果:xai驱动的CAD系统检测CXR异常的准确率为0.84(95%置信区间[CI] 0.82-0.86), NPV为1.00 (95% CI 0.99-1.00)。对于结节影的确定,其准确性为0.94 (95% CI 0.92-0.95), NPV为1.00 (95% CI 0.99-1.00),不逊于肺科专家。它倾向于高估心脏增大和胸膜增厚的异常,并倾向于降低敏感性。结论:似乎在未来,最准确的筛查CXR将是与肺科专家结合xai驱动的CAD系统进行双重检查。
{"title":"Utilization of Explainable Artificial Intelligence (XAI)-Powered Computer-Aided Detection (CAD) System on Chest X-Ray Abnormalities in Health Check-Ups.","authors":"Shizuka Nishii, Katsuyuki Tomita, Hirokazu Touge, Hiroyuki Yamamoto, Keiji Shigeshiro, Akira Yamasaki","doi":"10.33160/yam.2025.08.002","DOIUrl":"10.33160/yam.2025.08.002","url":null,"abstract":"<p><strong>Background: </strong>We designed a single-center retrospective study comparing the performance of commercially explainable artificial intelligence (XAI)-powered computer-aided detection (CAD) system of abnormal findings on chest X-rays (CXR) with that of non-experts, and pulmonology experts.</p><p><strong>Methods: </strong>A total of 1,262 images of 1,262 subjects (mean age 49 years; 52% female) and 1,252 images of 1,252 subjects (mean age 51 years; 51% female) were obtained from DICOM formats in Hakuai Hospital Health Check-up Center, in the pre-and post-implementing XAI-powered CAD period, respectively. The ultimate decision of abnormality on CXR was made by two pulmonology experts. The diagnostic accuracy metrics were measured accuracy and negative predictive value (NPV) for detecting abnormality on CXR.</p><p><strong>Results: </strong>XAI-powered CAD systems achieved an accuracy of 0.84 (95% confidential interval [CI] 0.82-0.86) and NPV of 1.00 (95% CI 0.99-1.00) to detect the abnormality on CXR. For determining nodular shadows, it was found to be non-inferior to the pulmonology experts with an accuracy of 0.94 (95% CI 0.92-0.95), and NPV of 1.00 (95% CI 0.99-1.00). It tended to overestimate the abnormality of heart enlargement and pleural thickening with a tendency for lower sensitivity.</p><p><strong>Conclusion: </strong>It seems likely that in the future, the most accurate screening CXR will be a double check combining with the pulmonology experts with XAI-powered CAD systems.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"68 3","pages":"180-186"},"PeriodicalIF":0.6,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12343184/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144849257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case of Perioperative Management of Tongue Cancer Polycythemia Vera. 舌癌真性红细胞增多症围手术期治疗1例。
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-07-17 eCollection Date: 2025-08-01 DOI: 10.33160/yam.2025.08.008
Soh Watanabe, Masanobu Inamura, Isamu Kodani

Polycythemia vera is a chronic myeloproliferative neoplasm characterized by a marked increase in circulating erythrocyte volume in middle-aged and elderly patients; it is associated with increased white blood cell and platelet counts and splenomegaly. There is a high risk of conflicting complications during surgical treatment, such as thrombosis and hemorrhage, with thrombosis being the leading cause of death. Hence, it is important to take measures against both in the perioperative management. We report a case of perioperative management of a patient with polycythemia vera and resection of an intraepithelial carcinoma of the tongue. The patient, a 46-year-old man, had been under observation at our hospital's Department of Internal Medicine for 10 years with a diagnosis of polycythemia vera. He came to our department with a complaint of white spots on the left tongue margin. Phlebotomy was performed when his blood count, hemoglobin, and hematocrit levels were elevated. The biopsy showed intraepithelial carcinoma. Preoperative examination revealed no abnormality, and a partial left-sided tongue resection was performed under general anesthesia. To prevent thromboembolism, the patient wore an elastic stocking from the time he entered the operating room. The patient underwent local hemostasis to prevent bleeding and systemic management centered on infusion therapy to prevent blood concentration. Four years and three months have passed since the surgery without recurrence.

真性红细胞增多症是一种慢性骨髓增生性肿瘤,其特点是中老年患者循环红细胞量显著增加;它与白细胞和血小板计数增加和脾肿大有关。手术治疗过程中出现相互矛盾的并发症的风险很高,如血栓形成和出血,而血栓形成是导致死亡的主要原因。因此,在围手术期的处理中,针对这两种情况采取措施是很重要的。我们报告一例真性红细胞增多症患者的围手术期治疗和舌上皮内癌的切除。患者男,46岁,诊断为真性红细胞增多症,在我院内科观察10年。他到我科来,说他左舌缘有白点。当他的血细胞计数、血红蛋白和红细胞比容水平升高时,进行了放血术。活检显示上皮内癌。术前检查未见异常,全麻下行左侧舌部部分切除。为了防止血栓栓塞,患者从进入手术室开始就穿着弹性长袜。患者接受局部止血以防止出血,并以输注治疗为中心进行全身管理以防止血药浓度升高。术后4年零3个月无复发。
{"title":"A Case of Perioperative Management of Tongue Cancer Polycythemia Vera.","authors":"Soh Watanabe, Masanobu Inamura, Isamu Kodani","doi":"10.33160/yam.2025.08.008","DOIUrl":"10.33160/yam.2025.08.008","url":null,"abstract":"<p><p>Polycythemia vera is a chronic myeloproliferative neoplasm characterized by a marked increase in circulating erythrocyte volume in middle-aged and elderly patients; it is associated with increased white blood cell and platelet counts and splenomegaly. There is a high risk of conflicting complications during surgical treatment, such as thrombosis and hemorrhage, with thrombosis being the leading cause of death. Hence, it is important to take measures against both in the perioperative management. We report a case of perioperative management of a patient with polycythemia vera and resection of an intraepithelial carcinoma of the tongue. The patient, a 46-year-old man, had been under observation at our hospital's Department of Internal Medicine for 10 years with a diagnosis of polycythemia vera. He came to our department with a complaint of white spots on the left tongue margin. Phlebotomy was performed when his blood count, hemoglobin, and hematocrit levels were elevated. The biopsy showed intraepithelial carcinoma. Preoperative examination revealed no abnormality, and a partial left-sided tongue resection was performed under general anesthesia. To prevent thromboembolism, the patient wore an elastic stocking from the time he entered the operating room. The patient underwent local hemostasis to prevent bleeding and systemic management centered on infusion therapy to prevent blood concentration. Four years and three months have passed since the surgery without recurrence.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"68 3","pages":"284-288"},"PeriodicalIF":0.6,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12343177/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144849252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Allogeneic Hematopoietic Stem Cell Transplantation for Older Patients with Hematological Malignancies. 异基因造血干细胞移植治疗老年血液系统恶性肿瘤。
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-07-17 eCollection Date: 2025-08-01 DOI: 10.33160/yam.2025.08.001
Koji Kawamura

Allogeneic hematopoietic stem cell transplantation (allo-HCT) has been established as a curative treatment for hematological malignancies such as acute myeloid leukemia and myelodysplastic syndrome. Patients aged ≥ 70 years have traditionally been considered ineligible for this procedure, because of concerns over high transplant-related mortality rates and difficulties managing post-transplant complications. However, recent advances in supportive care, expanded donor availability, and the development of reduced-intensity conditioning (RIC) regimens have increased the availability of allo-HCT for older patients. Notably, the number of allo-HCT procedures performed in patients aged ≥ 70 has been steadily increasing in Japan and Western countries, reflecting a re-evaluation of transplant eligibility in older patients. When assessing transplant eligibility in older patients, it is crucial to consider not only disease risk stratification and treatment response, but also comprehensive evaluations of general health status, comorbidities, cognitive function, and social backgrounds. In particular, indexes such as the Hematopoietic Cell Transplantation-Comorbidity Index and Comprehensive Geriatric Assessment have proven useful for predicting patient prognoses and non-relapse mortality. Donor selection and the intensity of the conditioning regimen used can both significantly influence transplant outcomes. RIC or non-myeloablative regimens are generally recommended for patients aged ≥ 70 years. Human leukocyte antigen-matched related or younger unrelated donors are preferred, while haploidentical donors or cord blood may be considered when matched donors are unavailable, although evidence in older patients is limited. This review provides a comprehensive overview of the current status of and challenges related to allo-HCT in patients aged ≥ 70 years. Patient eligibility, conditioning strategies, donor selection, and transplant outcomes are discussed in detail, based on the latest available evidence.

同种异体造血干细胞移植(Allogeneic hematopoietic stem cell transplantation, allo-HCT)已被确立为治疗血液系统恶性肿瘤如急性髓系白血病和骨髓增生异常综合征的有效方法。年龄≥70岁的患者传统上被认为不适合这种手术,因为担心移植相关的高死亡率和移植后并发症的处理困难。然而,最近支持性治疗的进展、供体可获得性的扩大以及降低强度调节(RIC)方案的发展增加了老年患者使用同种异体hct的可获得性。值得注意的是,在日本和西方国家,年龄≥70岁的患者中进行的同种异体hct手术数量一直在稳步增加,这反映了对老年患者移植资格的重新评估。在评估老年患者的移植资格时,不仅要考虑疾病风险分层和治疗反应,还要综合评估一般健康状况、合并症、认知功能和社会背景。特别是,诸如造血细胞移植-合并症指数和综合老年评估等指标已被证明可用于预测患者预后和非复发死亡率。供体选择和使用的调理方案的强度都可以显著影响移植结果。对于年龄≥70岁的患者,一般推荐使用RIC或非清髓方案。人类白细胞抗原匹配的相关或年轻的非相关献血者是首选,而单倍体相同的献血者或脐带血在没有匹配的献血者时可以考虑,尽管老年患者的证据有限。本综述全面概述了年龄≥70岁患者的同种异体hct的现状和挑战。根据最新的证据,详细讨论了患者资格,调节策略,供体选择和移植结果。
{"title":"Allogeneic Hematopoietic Stem Cell Transplantation for Older Patients with Hematological Malignancies.","authors":"Koji Kawamura","doi":"10.33160/yam.2025.08.001","DOIUrl":"10.33160/yam.2025.08.001","url":null,"abstract":"<p><p>Allogeneic hematopoietic stem cell transplantation (allo-HCT) has been established as a curative treatment for hematological malignancies such as acute myeloid leukemia and myelodysplastic syndrome. Patients aged ≥ 70 years have traditionally been considered ineligible for this procedure, because of concerns over high transplant-related mortality rates and difficulties managing post-transplant complications. However, recent advances in supportive care, expanded donor availability, and the development of reduced-intensity conditioning (RIC) regimens have increased the availability of allo-HCT for older patients. Notably, the number of allo-HCT procedures performed in patients aged ≥ 70 has been steadily increasing in Japan and Western countries, reflecting a re-evaluation of transplant eligibility in older patients. When assessing transplant eligibility in older patients, it is crucial to consider not only disease risk stratification and treatment response, but also comprehensive evaluations of general health status, comorbidities, cognitive function, and social backgrounds. In particular, indexes such as the Hematopoietic Cell Transplantation-Comorbidity Index and Comprehensive Geriatric Assessment have proven useful for predicting patient prognoses and non-relapse mortality. Donor selection and the intensity of the conditioning regimen used can both significantly influence transplant outcomes. RIC or non-myeloablative regimens are generally recommended for patients aged ≥ 70 years. Human leukocyte antigen-matched related or younger unrelated donors are preferred, while haploidentical donors or cord blood may be considered when matched donors are unavailable, although evidence in older patients is limited. This review provides a comprehensive overview of the current status of and challenges related to allo-HCT in patients aged ≥ 70 years. Patient eligibility, conditioning strategies, donor selection, and transplant outcomes are discussed in detail, based on the latest available evidence.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"68 3","pages":"169-179"},"PeriodicalIF":0.6,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12343187/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144849167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Localized Nodular Amyloidosis of the Buccal Mucosa Associated with Sjögren's Syndrome: A Case Report and Literature Review. 与Sjögren综合征相关的口腔黏膜局部结节性淀粉样变1例报告及文献复习。
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-07-14 eCollection Date: 2025-08-01 DOI: 10.33160/yam.2025.08.009
Rieko Doi, Kiharu Shimizu, Nobuyuki Fujii, Kosuke Sakai, Makoto Kawasaki, Takayuki Tamura, Isamu Kodani

Amyloidosis is a group of disorders in which specific precursor proteins form insoluble amyloid fibrils are deposited in various organs and extracellular spaces. Sjögren's syndrome (SS) is a chronic inflammatory disease in which lymphocytes infiltrate the exocrine glands, such as the salivary and lacrimal glands, through an autoimmune mechanism. At advanced stages of SS, localized nodular amyloidosis has been reported in specific organs outside the glands. Herein, we report a case of localized nodular amyloidosis associated with SS. An 80-year-old woman, who had been biting her buccal mucosa for several years and was aware of the presence of a mass, which had increased in size since approximately 6 months, was referred to our hospital. The patient had a history of SS and systemic lupus erythematosus since her 50s. A needle biopsy was performed because malignancy was suspected by magnetic resonance imaging. The pathological diagnosis was ATTR-type amyloidosis. The patient underwent excision of the lesion to improve the swelling. The pathological findings showed plasma cell infiltration in some areas, which required differentiation from AL amyloidosis; therefore, the patient was referred to a facility specializing in amyloidosis. The pathological diagnosis was AL amyloidosis. Various clinical findings ruled out systemic involvement and the final pathological diagnosis was localized nodular amyloidosis. It has been reported that it may occur in the advanced stages of SS, and our patient had SS for 30 years. One year after the surgery, the patient's prognosis was good.

淀粉样变性是一组疾病,其中特定的前体蛋白形成不溶性淀粉样原纤维沉积在各种器官和细胞外空间。Sjögren综合征(SS)是一种慢性炎症性疾病,其中淋巴细胞通过自身免疫机制浸润外分泌腺,如唾液腺和泪腺。在SS晚期,在腺体外的特定器官中有局限性结节性淀粉样变性的报道。在此,我们报告一例与SS相关的局部结节性淀粉样变病例。一位80岁的女性,多年来一直咬她的口腔黏膜,并意识到肿块的存在,大约6个月以来体积增加,被转介到我们医院。患者自50多岁起有SS和系统性红斑狼疮病史。由于磁共振成像怀疑有恶性肿瘤,因此进行了针活检。病理诊断为atr型淀粉样变。病人接受了病灶切除以改善肿胀。病理表现为部分部位浆细胞浸润,需与AL淀粉样变性鉴别;因此,患者被转介到专门治疗淀粉样变的机构。病理诊断为AL淀粉样变。各种临床表现排除了全身性病变,最终病理诊断为局限性结节性淀粉样变性。据报道,它可能发生在SS的晚期,我们的患者患有SS 30年。术后一年,患者预后良好。
{"title":"Localized Nodular Amyloidosis of the Buccal Mucosa Associated with Sjögren's Syndrome: A Case Report and Literature Review.","authors":"Rieko Doi, Kiharu Shimizu, Nobuyuki Fujii, Kosuke Sakai, Makoto Kawasaki, Takayuki Tamura, Isamu Kodani","doi":"10.33160/yam.2025.08.009","DOIUrl":"10.33160/yam.2025.08.009","url":null,"abstract":"<p><p>Amyloidosis is a group of disorders in which specific precursor proteins form insoluble amyloid fibrils are deposited in various organs and extracellular spaces. Sjögren's syndrome (SS) is a chronic inflammatory disease in which lymphocytes infiltrate the exocrine glands, such as the salivary and lacrimal glands, through an autoimmune mechanism. At advanced stages of SS, localized nodular amyloidosis has been reported in specific organs outside the glands. Herein, we report a case of localized nodular amyloidosis associated with SS. An 80-year-old woman, who had been biting her buccal mucosa for several years and was aware of the presence of a mass, which had increased in size since approximately 6 months, was referred to our hospital. The patient had a history of SS and systemic lupus erythematosus since her 50s. A needle biopsy was performed because malignancy was suspected by magnetic resonance imaging. The pathological diagnosis was ATTR-type amyloidosis. The patient underwent excision of the lesion to improve the swelling. The pathological findings showed plasma cell infiltration in some areas, which required differentiation from AL amyloidosis; therefore, the patient was referred to a facility specializing in amyloidosis. The pathological diagnosis was AL amyloidosis. Various clinical findings ruled out systemic involvement and the final pathological diagnosis was localized nodular amyloidosis. It has been reported that it may occur in the advanced stages of SS, and our patient had SS for 30 years. One year after the surgery, the patient's prognosis was good.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"68 3","pages":"289-296"},"PeriodicalIF":0.6,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12343191/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144849173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidural Anesthesia Is Effective in Lower-Extremity Burn Pain Treatment: A Case Report. 硬膜外麻醉对下肢烧伤痛的有效治疗:1例报告。
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-07-12 eCollection Date: 2025-08-01 DOI: 10.33160/yam.2025.08.007
Yusuke Minamigawa, Hiroshi Ichibakase, Tomofumi Ogoshi, Takahiro Ueda

Burn wounds cause pain through various mechanisms, making pain management challenging. Although treatment and management strategies for healing burns have been developed, clear guidelines for analgesia in burn injuries are lacking. Opioids are commonly used for pain relief, but regional anesthesia performed by anesthesiologists has shown effectiveness in some cases. We encountered a case in which epidural anesthesia was effective for analgesia of a lower-extremity burn injury in a 19-year-old man. The patient with burn injuries to his lower extremities was transferred to the emergency department. On the day of the injury, an epidural catheter was administered for burn pain. The epidural anesthesia was removed during hospitalization, but the pain worsened, so it was placed again to provide adequate analgesia. In this case, epidural anesthesia proved effective for managing the lower-extremity burn pain and facilitated patient rehabilitation. Epidural anesthesia should be actively considered for the management of burn pain.

烧伤伤口通过各种机制引起疼痛,使疼痛管理具有挑战性。虽然已经制定了烧伤愈合的治疗和管理策略,但缺乏烧伤镇痛的明确指导方针。阿片类药物通常用于缓解疼痛,但由麻醉师进行的区域麻醉在某些情况下显示出有效性。我们遇到了一个病例硬膜外麻醉是有效的镇痛下肢烧伤在一个19岁的男子。这位下肢烧伤的病人被转到急诊科。在受伤当天,硬膜外导管被用于治疗烧伤疼痛。住院期间解除了硬膜外麻醉,但疼痛加重,因此再次放置硬膜外麻醉以提供足够的镇痛。在这个病例中,硬膜外麻醉被证明是有效的管理下肢烧伤疼痛和促进患者康复。硬膜外麻醉应积极考虑管理烧伤疼痛。
{"title":"Epidural Anesthesia Is Effective in Lower-Extremity Burn Pain Treatment: A Case Report.","authors":"Yusuke Minamigawa, Hiroshi Ichibakase, Tomofumi Ogoshi, Takahiro Ueda","doi":"10.33160/yam.2025.08.007","DOIUrl":"10.33160/yam.2025.08.007","url":null,"abstract":"<p><p>Burn wounds cause pain through various mechanisms, making pain management challenging. Although treatment and management strategies for healing burns have been developed, clear guidelines for analgesia in burn injuries are lacking. Opioids are commonly used for pain relief, but regional anesthesia performed by anesthesiologists has shown effectiveness in some cases. We encountered a case in which epidural anesthesia was effective for analgesia of a lower-extremity burn injury in a 19-year-old man. The patient with burn injuries to his lower extremities was transferred to the emergency department. On the day of the injury, an epidural catheter was administered for burn pain. The epidural anesthesia was removed during hospitalization, but the pain worsened, so it was placed again to provide adequate analgesia. In this case, epidural anesthesia proved effective for managing the lower-extremity burn pain and facilitated patient rehabilitation. Epidural anesthesia should be actively considered for the management of burn pain.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"68 3","pages":"280-283"},"PeriodicalIF":0.6,"publicationDate":"2025-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12343183/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144849170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health Promotion and Digital Tools: Analysis of Consumer Demands. 健康促进与数字工具:消费者需求分析。
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-07-09 eCollection Date: 2025-08-01 DOI: 10.33160/yam.2025.08.003
Minoru Kouzuki

Background: A survey was conducted to determine the demand for the use of digital health content for health promotion, both among those interested in using digital tools and those interested in health promotion.

Methods: This study targeted smartphone owners who attended a class on how to use a smartphone (CS) and/or a class on advancements in health (CH) held in Nanbu Town. The main questionnaire items included questions on age, gender, frailty, subjective cognitive decline (SCD), smartphone usage, and interest in health promotion using digital technology. An analysis was conducted on 33 participants in the CS and 33 participants from the CH who provided complete responses to the questionnaire.

Results: The percentages of interest in using smartphones for accessing content on exercise, cognitive training, and nutrition management were 97.0%, 97.0%, and 87.9%, respectively, among CS participants and 69.7%, 78.8%, and 81.8%, respectively, among CH participants. The percentage of responses regarding interest in exercise content was significantly different between the two groups. Furthermore, some individuals responded that they were interested but concerned about how to use the services. No statistically significant differences were found with respect to the comparison of the percentages of responses by age group, frailty determination results, and SCD determination results among the participants of the CS and CR groups.

Conclusion: Regardless of age or the risk of developing health problems, there is demand for content related to health promotion using digital tools for those who want to master digital tools and who want to improve their health. However, support should be provided to them to ensure that they correctly use those tools. Notably, some individuals who want to improve their health are not interested in using digital tools.

背景:进行了一项调查,以确定对使用数字工具感兴趣的人和对健康促进感兴趣的人对使用数字健康内容进行健康促进的需求。方法:本研究的对象是参加了在南埠镇举办的智能手机使用课程(CS)和/或健康进步课程(CH)的智能手机用户。主要问卷项目包括年龄、性别、虚弱程度、主观认知能力下降(SCD)、智能手机使用情况以及对使用数字技术促进健康的兴趣。对33名CS参与者和33名CH参与者进行了分析,他们提供了完整的问卷回答。结果:CS参与者对使用智能手机获取运动、认知训练和营养管理内容的兴趣比例分别为97.0%、97.0%和87.9%,CH参与者分别为69.7%、78.8%和81.8%。关于对运动内容感兴趣的回答百分比在两组之间有显著差异。此外,一些个人回答说,他们感兴趣,但关心如何使用这些服务。CS组和CR组的应答百分率、虚弱度测定结果和SCD测定结果比较,差异无统计学意义。结论:无论年龄大小或存在健康问题的风险,对于想要掌握数字工具和想要改善健康的人来说,使用数字工具促进健康的相关内容是有需求的。但是,应该向他们提供支持,以确保他们正确使用这些工具。值得注意的是,一些希望改善健康状况的人对使用数字工具不感兴趣。
{"title":"Health Promotion and Digital Tools: Analysis of Consumer Demands.","authors":"Minoru Kouzuki","doi":"10.33160/yam.2025.08.003","DOIUrl":"10.33160/yam.2025.08.003","url":null,"abstract":"<p><strong>Background: </strong>A survey was conducted to determine the demand for the use of digital health content for health promotion, both among those interested in using digital tools and those interested in health promotion.</p><p><strong>Methods: </strong>This study targeted smartphone owners who attended a class on how to use a smartphone (CS) and/or a class on advancements in health (CH) held in Nanbu Town. The main questionnaire items included questions on age, gender, frailty, subjective cognitive decline (SCD), smartphone usage, and interest in health promotion using digital technology. An analysis was conducted on 33 participants in the CS and 33 participants from the CH who provided complete responses to the questionnaire.</p><p><strong>Results: </strong>The percentages of interest in using smartphones for accessing content on exercise, cognitive training, and nutrition management were 97.0%, 97.0%, and 87.9%, respectively, among CS participants and 69.7%, 78.8%, and 81.8%, respectively, among CH participants. The percentage of responses regarding interest in exercise content was significantly different between the two groups. Furthermore, some individuals responded that they were interested but concerned about how to use the services. No statistically significant differences were found with respect to the comparison of the percentages of responses by age group, frailty determination results, and SCD determination results among the participants of the CS and CR groups.</p><p><strong>Conclusion: </strong>Regardless of age or the risk of developing health problems, there is demand for content related to health promotion using digital tools for those who want to master digital tools and who want to improve their health. However, support should be provided to them to ensure that they correctly use those tools. Notably, some individuals who want to improve their health are not interested in using digital tools.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"68 3","pages":"187-196"},"PeriodicalIF":0.6,"publicationDate":"2025-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12343190/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144849171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of Gabapentin for Paroxysmal Sympathetic Hyperactivity in Three Children with Severe Motor and Intellectual Disability due to Neonatal Hypoxic Ischemic Encephalopathy. 加巴喷丁治疗新生儿缺氧缺血性脑病所致严重运动和智力障碍患儿阵发性交感神经亢进3例
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-07-09 eCollection Date: 2025-08-01 DOI: 10.33160/yam.2025.08.006
Go Yoshino, Tohru Okanishi, Hiroyuki Yamada, Tatsuya Kawaguchi, Masahiro Umeda, Yuto Arai, Yoshihiro Maegaki

Paroxysmal sympathetic hyperactivity (PSH) is a clinical syndrome characterized by recurrent episodes of sympathetic overactivity, including hypertonia, tachycardia, hypertension, and hyperthermia, typically following severe brain injury. While PSH is well documented in adult populations, reports on pediatric patients, particularly those with severe motor and intellectual disabilities (SMID), remain limited. Here, we report three pediatric patients with SMID due to neonatal hypoxic-ischemic encephalopathy (NHIE) who developed PSH. All patients presented with characteristic PSH symptoms and were diagnosed according to the Pediatric Clinical Practice Guidelines based on the 2014 consensus criteria. Gabapentin (GBP) was initiated at low doses (5-10 mg/kg/day) in all patients, resulting in the rapid resolution of PSH symptoms. In two patients, symptoms partially recurred within several months but were controlled through GBP dose adjustment and the addition of clonidine or other agents. No severe adverse events were observed. To our knowledge, this is the first report describing the short-term efficacy of GBP in pediatric patients who developed PSH with SMID status due to NHIE. Our findings suggest that GBP is a valuable and well-tolerated therapeutic option for the management of PSH in children with these conditions.

阵发性交感神经亢进(PSH)是一种临床综合征,以交感神经亢进反复发作为特征,包括高张力、心动过速、高血压和高热,通常发生在严重脑损伤后。虽然PSH在成人人群中有很好的记录,但关于儿科患者,特别是那些患有严重运动和智力残疾(SMID)的儿童患者的报道仍然有限。在这里,我们报告了3例因新生儿缺氧缺血性脑病(NHIE)而患有SMID的儿童患者,他们发展为PSH。所有患者均表现出PSH特征性症状,并根据基于2014年共识标准的儿科临床实践指南进行诊断。在所有患者中,加巴喷丁(GBP)以低剂量(5-10 mg/kg/天)开始治疗,导致PSH症状迅速消退。2例患者症状在几个月内部分复发,但通过调整GBP剂量和添加可乐定或其他药物得到控制。未观察到严重的不良事件。据我们所知,这是第一份描述GBP在因NHIE而发展为PSH并伴有SMID状态的儿科患者中的短期疗效的报告。我们的研究结果表明,对于患有这些疾病的儿童,GBP是一种有价值且耐受性良好的PSH治疗选择。
{"title":"Use of Gabapentin for Paroxysmal Sympathetic Hyperactivity in Three Children with Severe Motor and Intellectual Disability due to Neonatal Hypoxic Ischemic Encephalopathy.","authors":"Go Yoshino, Tohru Okanishi, Hiroyuki Yamada, Tatsuya Kawaguchi, Masahiro Umeda, Yuto Arai, Yoshihiro Maegaki","doi":"10.33160/yam.2025.08.006","DOIUrl":"10.33160/yam.2025.08.006","url":null,"abstract":"<p><p>Paroxysmal sympathetic hyperactivity (PSH) is a clinical syndrome characterized by recurrent episodes of sympathetic overactivity, including hypertonia, tachycardia, hypertension, and hyperthermia, typically following severe brain injury. While PSH is well documented in adult populations, reports on pediatric patients, particularly those with severe motor and intellectual disabilities (SMID), remain limited. Here, we report three pediatric patients with SMID due to neonatal hypoxic-ischemic encephalopathy (NHIE) who developed PSH. All patients presented with characteristic PSH symptoms and were diagnosed according to the Pediatric Clinical Practice Guidelines based on the 2014 consensus criteria. Gabapentin (GBP) was initiated at low doses (5-10 mg/kg/day) in all patients, resulting in the rapid resolution of PSH symptoms. In two patients, symptoms partially recurred within several months but were controlled through GBP dose adjustment and the addition of clonidine or other agents. No severe adverse events were observed. To our knowledge, this is the first report describing the short-term efficacy of GBP in pediatric patients who developed PSH with SMID status due to NHIE. Our findings suggest that GBP is a valuable and well-tolerated therapeutic option for the management of PSH in children with these conditions.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"68 3","pages":"275-279"},"PeriodicalIF":0.6,"publicationDate":"2025-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12343186/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144849256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psychological Factors Related to Social Exclusion of Hikikomori (Prolonged Social Withdrawal) Individuals by Local Residents. 当地居民对“隐蔽青年”社会排斥的相关心理因素。
IF 0.9 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-05-18 eCollection Date: 2025-05-01 DOI: 10.33160/yam.2025.05.011
Shinya Takeda, Maki Ota, Yuki Fujii, Kosuke Fujiyoshi, Jin Hiroe, Sumire Hiroe, Mae Hirosawa, Mitsue Kawakami, Rie Kikumoto, Yuri Maezawa, Kazuyoshi Morimoto, Yohei Nagami, Chisato Takashima, Hideyuki Tazumi, Mari Yamamoto, Reeya Komoda

Background: The number of hikikomori individuals has been increasing not only in Japan but also worldwide while few studies have looked into the societal elements that could lead to further isolation of hikikomori individuals. This study examines the psychological factors in local residents related to social exclusion of hikikomori individuals.

Methods: 365 participants living in Tottori, Japan were analyzed. The questionnaire includes key questions such as social exclusion of hikikomori individuals, daily lifestyle, personal opinions and attitudes towards hikikomori individuals.

Results: Those who are unwilling to interact with people who have different sense of values were 3.6 times likely to exclude hikikomori individuals than those who did not. Those who believe that hikikomori is a family issue so that others should not intervene were 2.2 times likely to exclude them than those who did not. Conversely, those who think that people can make a fresh start in the society even after making mistakes were 0.5 times likely to exclude hikikomori than those who did not. Those who feel that they have something in common with hikikomori individuals were 0.4 times likely to exclude them than those who did not. Those who think that they can enjoy activities such as hobbies together with hikikomori individuals were 0.3 times likely to exclude them than those who did not.

Conclusion: The analysis indicates that the tendency to reject relationships with people who have different sense of values and the opinion that hikikomori is a family issue are the risk factors for social exclusion of hikikomori individuals. Contrarily, the opinion that even if we make a mistake or fail, we can make a fresh start, awareness of the similarities between oneself and hikikomori individuals, and willingness to share enjoyable activities with them are shown to be the protective factors which could reduce social exclusion of hikikomori.

背景:不仅在日本,而且在世界范围内,隐蔽青年的人数一直在增加,但很少有研究调查可能导致隐蔽青年进一步孤立的社会因素。本研究探讨与“隐蔽青年”社会排斥相关的当地居民心理因素。方法:对居住在日本鸟取县的365名参与者进行分析。问卷包括社会对“隐蔽青年”的排斥、日常生活方式、个人对“隐蔽青年”的看法和态度等关键问题。结果:那些不愿与价值观不同的人交往的人排斥“隐蔽青年”的可能性是那些不愿与之交往的人的3.6倍。那些认为“隐蔽青年”是家庭问题,其他人不应该干预的人排斥他们的可能性是那些不这么认为的人的2.2倍。相反,那些认为即使犯错也能重新开始的人排斥“隐蔽青年”的可能性是那些认为没有犯错的人的0.5倍。那些认为自己与“隐蔽青年”有共同之处的人排斥他们的可能性是那些没有共同之处的人的0.4倍。那些认为可以和“隐蔽青年”一起享受爱好等活动的人排斥“隐蔽青年”的可能性是不这样认为的人的0.3倍。结论:分析表明,拒绝与价值观不同的人交往的倾向以及认为“隐蔽青年”是家庭问题是导致“隐蔽青年”个体被社会排斥的危险因素。相反,即使我们犯了错误或失败,我们也可以重新开始的观点,意识到自己与“隐蔽青年”之间的相似之处,并愿意与他们分享愉快的活动,被证明是可以减少社会对“隐蔽青年”的排斥的保护因素。
{"title":"Psychological Factors Related to Social Exclusion of Hikikomori (Prolonged Social Withdrawal) Individuals by Local Residents.","authors":"Shinya Takeda, Maki Ota, Yuki Fujii, Kosuke Fujiyoshi, Jin Hiroe, Sumire Hiroe, Mae Hirosawa, Mitsue Kawakami, Rie Kikumoto, Yuri Maezawa, Kazuyoshi Morimoto, Yohei Nagami, Chisato Takashima, Hideyuki Tazumi, Mari Yamamoto, Reeya Komoda","doi":"10.33160/yam.2025.05.011","DOIUrl":"10.33160/yam.2025.05.011","url":null,"abstract":"<p><strong>Background: </strong>The number of hikikomori individuals has been increasing not only in Japan but also worldwide while few studies have looked into the societal elements that could lead to further isolation of hikikomori individuals. This study examines the psychological factors in local residents related to social exclusion of hikikomori individuals.</p><p><strong>Methods: </strong>365 participants living in Tottori, Japan were analyzed. The questionnaire includes key questions such as social exclusion of hikikomori individuals, daily lifestyle, personal opinions and attitudes towards hikikomori individuals.</p><p><strong>Results: </strong>Those who are unwilling to interact with people who have different sense of values were 3.6 times likely to exclude hikikomori individuals than those who did not. Those who believe that hikikomori is a family issue so that others should not intervene were 2.2 times likely to exclude them than those who did not. Conversely, those who think that people can make a fresh start in the society even after making mistakes were 0.5 times likely to exclude hikikomori than those who did not. Those who feel that they have something in common with hikikomori individuals were 0.4 times likely to exclude them than those who did not. Those who think that they can enjoy activities such as hobbies together with hikikomori individuals were 0.3 times likely to exclude them than those who did not.</p><p><strong>Conclusion: </strong>The analysis indicates that the tendency to reject relationships with people who have different sense of values and the opinion that hikikomori is a family issue are the risk factors for social exclusion of hikikomori individuals. Contrarily, the opinion that even if we make a mistake or fail, we can make a fresh start, awareness of the similarities between oneself and hikikomori individuals, and willingness to share enjoyable activities with them are shown to be the protective factors which could reduce social exclusion of hikikomori.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"68 2","pages":"144-151"},"PeriodicalIF":0.9,"publicationDate":"2025-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12104581/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144162526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Yonago acta medica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1